₹ 1,010.50
87.00 (9.42%)
A
Aarti Pharma Labs
₹ 1,010.50
Aarti Pharma Labs Share Price Today
Aarti Pharma Labs (AARTIPHARM) share price is trading at ₹1,010.50 on the NSE as of November 12, 2026 at 03:56 PM, up by 9.42% from its previous close of ₹923.50. In todays trading session AARTIPHARM reached a high of 1,019.00 and low of 924.80. The average traded price for today is 988.19. The 50 DMA stands at 886.92 and 200 DMA is at 755.01. Looking at intraday trend, the stock is in Uptrend.
Stock Overview
- Symbol : AARTIPHARM
- Open : ₹929.00
- Previous Close : ₹923.50
- Day's Range : ₹924.80 – ₹1,019.00
- 52-Week Range : ₹585.00 – ₹1,019.00
Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.
AARTIPHARM Stock Performance
Markets Today
High
1,019.00
Low
924.80
Open at
929.00
Prev Close
923.50
Volumes
17,79,924
Avg Price
988.19
Lower Circuit
808.40
Upper Circuit
1,212.60
Last Traded Details
Quantity
1
Time
15:56:15
Price Movement
Historical Performance
3 M High
1,019.00
3 M Low
765.00
1 Yr High
1,019.00
1 Yr Low
585.00
3 Yr High
1,019.00
3 Yr Low
388.35
5 Yr High
1,019.00
5 Yr Low
234.80
1-Year Performance
AARTIPHARM Pros and Cons
Operational Revenue grew from ₹4,173 Cr in Q2 FY26 to ₹6,105 Cr in Q2 FY27 — consistent top-line expansion
EBITDA increased from ₹741 Cr in Q2 FY26 to ₹1,346 Cr in Q2 FY27 — stronger operating profits
PAT Margin expanded from 7.40% in Q2 FY26 to 11.71% in Q2 FY27 — improved bottom-line efficiency
Market Price rose from ₹589.25 in Q4 FY26 to ₹952.25 in Q2 FY27 — strong investor confidence rebound
Share of JV profit turned positive from -₹6 Cr in Q2 FY26 to ₹69 Cr in Q2 FY27 — joint ventures contributing meaningfully
Finance Costs rose from ₹107 Cr in Q2 FY26 to ₹150 Cr in Q2 FY27 — higher borrowing costs impacting net profit
Promoter Holding dropped from 43.08% in Q4 FY26 to 39.66% in Q2 FY27 — reduction in promoter stake
Operating Expenses increased from ₹3,432 Cr in Q2 FY26 to ₹4,759 Cr in Q2 FY27 — cost base expanding alongside revenue
AARTIPHARM Analyst Rating
Hold
Analysts have suggested that investors can
Hold this Stock
- By Refinitiv from 1 analysts
Buy
0%
Hold
100%
Sell
0%
Get forecast for Price, ROA & ROE based on analyst ratings.
AARTIPHARM Share Price History
AARTIPHARM Fundamentals
Company Valuation
Market Cap (₹ Cr.)
9,163
PE Ratio
32.70
PB Ratio
3.72
Dividend Yield
0.38%
ROE
8.22%
ROCE
11.00%
Book Value (₹)
248.65
Face Value (₹)
5.00
Analyse AARTIPHARM with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 42.88% | 43.10% | 43.08% | 42.86% | 39.66% |
| Domestic Institutional Investors (DII) | 6.96% | 7.66% | 7.41% | 7.22% | 8.40% |
| Foreign Institutional Investors (FII) | 8.02% | 7.68% | 8.39% | 8.17% | 8.15% |
| Public Investors | 35.39% | 34.85% | 34.29% | 34.39% | 35.65% |
| Government | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
Aarti Pharma Labs Return Calculator
Note: Past profits do not guarantee future returns.
AARTIPHARM Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
AARTIPHARM Technicals
Moving Averages
Technical Indicators
Summary of Technical Indicators for AARTIPHARM
Margin on AARTIPHARM
*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).
AARTIPHARM Financials Summary
In Crores
AARTIPHARM Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Corporate Actions
The above dates are ex-dates.
Check AARTIPHARM latest Company Filings, Investor Presentation & Conference Call details.
AARTIPHARM Revenue Growth
All values are in Crores
Revenue
Profit
Loss
AARTIPHARM Similar Stocks
FAQs on AARTIPHARM
What is the share price of Aarti Pharma Labs?
What is the 52W high and 52W low of Aarti Pharma Labs?
What is the return on Aarti Pharma Labs share?
- Past 1 year: 30.97%
- Past 3 years: 156.90%
- Past 5 years: 250.56%
What is the PE and PB Ratio of Aarti Pharma Labs?
What is the EPS of Aarti Pharma Labs?
What is the shareholding pattern of Aarti Pharma Labs?
- DIIs - 8.40%
- FII - 8.15%
- Promoters - 39.66%
- Public Investors 35.65%
- Goverenment - 0.01%
How to buy Aarti Pharma Labs shares online?
How to buy Aarti Pharma Labs shares on Dhan?
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Aarti Pharma Labs share
- Tap on “Buy”
